CIK 0001077183
- Large accelerated filer
NEOGENOMICS INC
Sign in to watch- Ticker
- NEO
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 742897368
- Phone
- +1 239-768-0600
- Business address
- 9490 NEOGENOMICS WAY, FORT MYERS, FL, 33912
- Former names
- AMERICAN COMMUNICATIONS ENTERPRISES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-25 | VAN OORT DOUGLAS M Chairman and CEO | Shares withheld for taxes | −22,330 | 2,293,743 | ||
| 2020-05-25 | SHOVLIN ROBERT J. President, Clinical Services | Shares withheld for taxes | −5,405 | 146,235 | ||
| 2020-05-01 | CROWTHER BRUCE K Director | Exercise or conversion | +10,000 | $4.78 | $48K | 46,185 |
| 2020-05-01 | CROWTHER BRUCE K Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2020-03-13 | JONES STEVEN C Director | Exercise or conversion | +125,000 | $4.78 | $598K | 1,500,000 |
| 2020-03-13 | JONES STEVEN C Director | Exercise or conversion · Stock Option (Right to Buy) | −125,000 | 0 | ||
| 2020-03-04 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion | +96,167 | $8.03 | $772K | 249,733 |
| 2020-03-04 | SHOVLIN ROBERT J. President, Clinical Services | Sale | −98,093 | $30.86 | $3.0M | 151,640 |
| 2020-03-04 | SHOVLIN ROBERT J. President, Clinical Services | Exercise or conversion · Stock Option (Right to Buy) | −96,167 | 96,167 | ||
| 2020-03-02 | JONES STEVEN C Director | Sale | −250,000 | $28.85 | $7.2M | 1,375,000 |
| 2020-03-02 | JONES STEVEN C Director | Sale | −25,000 | $28.48 | $712K | 125,000 |
| 2020-03-02 | JONES STEVEN C Director | Sale | −2,300 | $28.24 | $65K | 40,757 |
| 2020-03-02 | JONES STEVEN C Director | Sale | −20,000 | $28.24 | $565K | 30,476 |
| 2020-03-02 | Bonello William President, Informatics | Grant or award | +5,824 | 12,060 | ||
| 2020-03-02 | Bonello William President, Informatics | Grant or award · Common Stock | +37,514 | $28.33 | $1.1M | 37,514 |
| 2020-03-02 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award | +2,330 | 24,980 | ||
| 2020-03-02 | BALLIET JENNIFER VP and Chief Culture Officer | Grant or award · Common Stock | +15,006 | $28.33 | $425K | 15,006 |
| 2020-03-02 | Pedulla Denise E General Counsel | Grant or award | +2,912 | 43,988 | ||
| 2020-03-02 | Pedulla Denise E General Counsel | Grant or award · Common Stock | +18,757 | $28.33 | $531K | 18,757 |
| 2020-03-02 | CARDOZA GEORGE President, Pharma Services | Grant or award | +7,571 | 333,402 |
Page 33 of 51 · 1,005 trades